Crispr Therapeutics shares owned by Natixis Asset Management Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Natixis Asset Management Advisors
from 13F filings
Historical chart of Natixis Asset Management Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Natixis Asset Management Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Natixis Asset Management Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $716k | 11k | 68.15 |
| 2023-12-31 | $634k | 10k | 62.52 |
| 2023-09-30 | $531k | 12k | 45.36 |
| 2023-06-30 | $675k | 12k | 56.18 |
| 2023-03-31 | $563k | 12k | 45.22 |
| 2022-12-31 | $519k | 13k | 40.69 |
| 2022-09-30 | $1.0M | 16k | 65.34 |
| 2022-06-30 | $1.0M | 17k | 60.76 |
| 2022-03-31 | $1.1M | 18k | 62.73 |
| 2021-12-31 | $1.3M | 18k | 75.75 |
| 2021-09-30 | $2.1M | 19k | 111.93 |
| 2021-06-30 | $1.6M | 10k | 161.91 |
More positions owned by Natixis Asset Management Advisors
View all positions for Natixis Asset Management Advisors